Drugs / V350A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06655324 | Dec 2024 → Jul 2028 expected | — | Merck Sharp & Dohme LLC | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | V350A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06655324 ↗ |
| Modality | Vaccine | “new study vaccine (V350A and V350B)” NCT06655324 ↗ |